急性白血病患者细胞周期蛋白E2的表达和耐药的关系
被引量：1
出处
《临床荟萃》
CAS
北大核心
2008年第7期506-508,共3页
Clinical Focus
基金
河北省医学科学研究重点项目(2005118)
参考文献9
-
1徐丽粉,郭晓楠.细胞周期蛋白E_2与肿瘤[J].临床荟萃,2007,22(23):1747-1748. 被引量：2
-
2Gudas JM, Payton M, Thukral S, et al. Cyelin E2, a novel G1 Cyclin that binds Cdk2 and is aberrantly expressed in human cancers[J]. Mol Cell Biol,1999,19(1) :612-622.
-
3Payton M,Scully S, Chung G, et al. Deregulation of Cyclin E2 expression and associated kinase activity in primary breast tumors[J]. Oncogene, 2002 , 21 (55) : 8529-8534.
-
4Zariwala M, Liu J, Xiong Y. Cyelin E2,a novel human G1 eyelin and activating partner of CDK2 and CDK3, is induced by viral oneoproteins[J]. Oneogene, 1998,17(21):2787-2798.
-
5Geng Y,Yu Q,Whoriskey W,et al. Expression of eyelins E1 and E2 during mouse development and in neoplasla[J]. Proc Natl Acad Sci USA. 2001,98(23) : 13138-13143.
-
6王建华,于丽莉,陈诗书.细胞周期蛋白E2基因的过度表达与胃腺癌细胞迁徙的关系[J].中国生物化学与分子生物学报,2003,19(2):137-143. 被引量：5
-
7Cheng SH, Ng MH, Tsang KS, et al. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression [J]. Int J Oncol, 2004, 24 ( 5 ) : 1141- 1148.
-
8王颖,郭晓楠,徐世荣,陈静,林凤茹.cyclin E2和survivin在急性白血病患者中的表达[J].中华血液学杂志,2005,26(9):571-572. 被引量：4
-
9郑文莉,谢兆霞,唐果成,谭达人.急性白血病患者白血病细胞DNA拓扑异构酶Ⅱ活性与多药耐药的研究[J].中华血液学杂志,1998,19(9):470-472. 被引量：14
二级参考文献28
-
1王颖,郭晓楠,徐世荣,陈静,林凤茹.cyclin E2和survivin在急性白血病患者中的表达[J].中华血液学杂志,2005,26(9):571-572. 被引量：4
-
2谢兆霞，湖南医科大学学报，1992年，17卷，63页
-
3Chen C J，J Biol Chem，1990年，265卷，506页
-
4Gudas JM, Payton M, Thukral S, et al. CyclinE2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol, 1999,19:612-622.
-
5Shinozawa I, Inokucbi K, Wakabayashi I, et al. Disturbed expression of the anti-apoptosis gene, survivin and Epr-1 in hematological malignancies. Leuk Res, 2000, 24:965-970.
-
6Jiang Y, Saavedra HI, Holloway MP, et al. Aberrant regulation of survivin by the RB/E2F family of proteins. J Biol Chem, 2004, 279:40511-40520.
-
7Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene, 2000,19: 1346-1353.
-
8Lida H,Towatari M, Tanimoto M, et al. Overexpression of cyclin E in acute myelogenous leukemia. Blood,1997,90:3707-3713.
-
9Payton M,Scully S, Chung G, et al. Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors[J]. Oncogene, 2002,21 ( 55 ) : 8529-8534.
-
10Cheng SH, Ng MH, Tsang KS, et al. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression[J]. Int J Oncol, 2004,24(5):1141- 1148.
共引文献20
-
1邓立春,姜藻.拓扑异构酶Ⅱ与肿瘤化疗[J].东南大学学报（医学版）,2005,24(4):284-287. 被引量：3
-
2楚刚,庄桂明,陶胜岩.白血病的多药耐药性及其逆转策略[J].食品与药品,2005,7(09A):40-43. 被引量：1
-
3刘梅,刘炎,林社裕,丁斐,顾晓松.Tropic1808基因作用于PC12细胞的表达谱芯片分析[J].中国生物化学与分子生物学报,2005,21(6):791-795.
-
4薛惠平,倪培华,吴洁敏,孙建华,童菊芳.细胞周期蛋白E2基因mRNA在胃癌组织中的表达[J].上海交通大学学报（医学版）,2007,27(1):95-98. 被引量：3
-
5徐丽粉,郭晓楠.细胞周期蛋白E_2与肿瘤[J].临床荟萃,2007,22(23):1747-1748. 被引量：2
-
6凌莉莉.拓扑异构酶Ⅱ抑制剂抗肿瘤作用机制的研究进展[J].哈尔滨医药,2007,27(6):50-51. 被引量：1
-
7罗文纪,虞荣喜.中医药逆转白血病细胞多药耐药的研究近况[J].湖南中医杂志,1999,15(5):52-54. 被引量：3
-
8徐丽粉,郭晓楠,刘英芳.细胞周期蛋白E2反义脱氧寡核苷酸对K562细胞增殖及凋亡的调控作用[J].临床荟萃,2012,27(1):39-41.
-
9徐丽粉,郭晓楠,刘英芳.白血病患者cyclin E2、CDK2的表达与复发的关系[J].临床荟萃,2012,27(5):410-412.
-
10林秀梅,谢兆霞,陈朝晖,李宁.难治/复发的急性白血病患者P-170的表达与染色体异常[J].湖南医科大学学报,2000,25(6):591-592.
同被引文献23
-
1史哲新,杨文华,汤毅,高宏,陈化禹,姚芳,张蕾,陈晓晖,王兴丽.六神丸逆转白血病细胞多药耐药作用及相关机制研究[J].天津中医药大学学报,2007,26(1):11-13. 被引量：34
-
2Zunino SJ, Storms DH, Ducore JM. Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromo- somal translocation t (4; 11 ). Cancer Lett, 2010, 296( 1 ):49-54.
-
3Fiegl M, Zimmermann I, Lorenz I, et al. In vitro cross-resistance to nucleoside analogues and inhibitors of topoisomerase 1 and 2 in acute myeloid leukemia. Ann Hematol, 2008, 87( 1 ) :27-33.
-
4Lehne G, Grasmo-Wendler UH, Berner JM, et al. Upregulation of stem cell genes in multidrug resistant K562 leukemia cells. Leuk Res, 2009, 33 (10) : 1379-1385.
-
5Chauhan PS, Bhushan B, Singh LC, et al. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy. Exp Mol Pathol, 2012, 92( 1 ) :44-49.
-
6Grundy M, Seedhouse C, Russell NH, et al. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia ceils trea- ted with the aurora-B kinase inhibitor barasertib-hQPA. BMC Cancer, 2011, 11:254.
-
7Chapuy B, Koch R, Radunski U, et al. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia, 2008, 22 ( 8 ) : 1576-1586.
-
8Stlzel F, Steudel C, Oelschlagel U, et al. Mechanisms of resistanceagainst PKC412 in resistant FL3"3-ITD positive human acute myeloid leukemia cells. Ann Hematol, 2010, 89(7) :653-662.
-
9Campana D. Molecular determinants of treatment response in acute lymphoblastic leukemia. Hematology Am Soc Hematol Edue Program, 2008 : 366 -373.
-
10Kim KT, Levis M, Small D. Constitutively activated FLT3 phospho- rylates BAD partially through pim-1. Br J Haematol, 2006, 134 ( 5 ) :500-509.
-
1赵光辉,谢国旗,缪应业.细胞周期蛋白E2在人鼻咽癌组织中的表达及临床意义[J].细胞与分子免疫学杂志,2012,28(3):291-293. 被引量：1
-
2薛惠平,倪培华,吴洁敏,孙建华,童菊芳.细胞周期蛋白E2基因mRNA在胃癌组织中的表达[J].上海交通大学学报（医学版）,2007,27(1):95-98. 被引量：3
-
3王颖,郭晓楠,徐世荣,陈静,林凤茹.cyclin E2和survivin在急性白血病患者中的表达[J].中华血液学杂志,2005,26(9):571-572. 被引量：4
-
4王颖,徐世荣,林凤茹,郭晓楠,任金海.CyclinE2和Survivin在急性白血病的表达及其相关性(英文)[J].中国实验血液学杂志,2006,14(2):337-342. 被引量：2
-
5徐丽粉,郭晓楠,刘英芳.细胞周期蛋白E2反义脱氧寡核苷酸对K562细胞增殖及凋亡的调控作用[J].临床荟萃,2012,27(1):39-41.
-
6徐丽粉,郭晓楠.细胞周期蛋白E_2与肿瘤[J].临床荟萃,2007,22(23):1747-1748. 被引量：2
-
7玄菲,徐芳.茶多酚联合莱菔硫烷对肺癌组织蛋白激酶A锚定蛋白95和细胞周期蛋白E2表达的影响[J].中国生化药物杂志,2014,34(4):73-75.
-
8徐丽粉,郭晓楠,刘英芳.白血病患者cyclin E2、CDK2的表达与复发的关系[J].临床荟萃,2012,27(5):410-412.
-
9王颖,王静,徐世荣,林凤茹,郭晓楠.细胞周期蛋白E2基因表达与白血病的关系[J].中华内科杂志,2005,44(10):777-778.
-
10张伟,王本忠.三阴乳腺癌的临床病理特征和预后分析[J].中华外科杂志,2011,49(5):453-455. 被引量：9
